Your browser doesn't support javascript.
loading
LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma.
Zhang, Hongbin; Xu, Ke; Xiang, Qin; Zhao, Lijuan; Tan, Benxu; Ju, Ping; Lan, Xiufu; Liu, Yi; Zhang, Jian; Fu, Zheng; Li, Chao; Wang, Jinzhi; Song, Jixiang; Xiao, Yun; Cheng, Zhaobo; Wang, Yan; Zhang, Shu; Xiang, Tingxiu.
Affiliation
  • Zhang H; Department of Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong 250117, PR China.
  • Xu K; Department of Oncology, People's Hospital of Juxian County, Rizhao, Shandong 276599, PR China.
  • Xiang Q; Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
  • Zhao L; Department of Oncology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan 610599, PR China.
  • Tan B; Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
  • Ju P; Department of Oncology, Yongchuan Hospital of Chongqing Medical University, Chongqing 402177, PR China.
  • Lan X; Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
  • Liu Y; College of Science and Mathematics, West Chester University of Pennsylvania, West Chester, PA 19383, USA.
  • Zhang J; Department of Orthopedics, Daping Hospital, Army Medical University, Chongqing 400042, PR China.
  • Fu Z; Engineering Department, Women & Children's Health Care Hospital of Linyi, Linyi, Shandong 276016, PR China.
  • Li C; Department of Oncology, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250013, PR China.
  • Wang J; Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong 250013, PR China.
  • Song J; Department of Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong 250117, PR China.
  • Xiao Y; Department of Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong 250117, PR China.
  • Cheng Z; Medical Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong 250013, PR China.
  • Wang Y; Department of Oncology, Chongqing Traditional Chinese Medicine Hospital, Chongqing 400042, PR China.
  • Zhang S; Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
  • Xiang T; Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
Genes Dis ; 9(1): 151-164, 2022 Jan.
Article in En | MEDLINE | ID: mdl-35005115
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Genes Dis Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Genes Dis Year: 2022 Type: Article